Conventional surgery and systemic chemotherapy for peritoneal carcinomatosis of colorectal origin: A prospective study

European Journal of Surgical Oncology

Volumn 31, Issue 10, 2005, Pages 1145-1151

  Bloemendaal, A L A ^a   Verwaal, V J ^a   van Ruth, S ^a   Boot, H ^a   Zoetmulder, F A N ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

Colorectal cancer; Conventional therapy; Peritoneal carcinomatosis

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; FOLINIC ACID; IRINOTECAN;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; CARCINOMATOUS PERITONITIS; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; STANDARDIZATION; SURVIVAL RATE; SURVIVAL TIME; TUMOR LOCALIZATION;

ADULT; AGED; ANTINEOPLASTIC AGENTS; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; PERITONEAL NEOPLASMS; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 29244491447     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2005.06.002     Document Type: Article

References (26)

1. A.C. Beaujard et al. Intraperitoneal chemohyperthermia with mitomycin C for digestive tract cancer patients with peritoneal carcinomatosis Cancer 88 2000 2512-2519
2. F. Cavaliere et al. Treatment of peritoneal carcinomatosis with intent to cure J Surg Oncol 74 2000 41-44
3. D. Elias et al. Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy Cancer 92 2001 71-76
4. B.W. Loggie R.A. Fleming R.P. McQuellon G.B. Russell K.R. Geisinger Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of gastrointestinal origin Am Surg 66 2000 561-568
5. P. Shen et al. Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosis Arch Surg 138 2003 26-33
6. P.H. Sugarbaker D. Chang Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy Ann Surg Oncol 6 1999 727-731
7. C.H. Kohne et al. Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer: Results of a multivariate analysis of 3825 patients Ann Oncol 13 2002 308-317
8. W.H. Isacoff K. Borud Chemotherapy for the treatment of patients with metastatic colorectal cancer: An overview World J Surg 21 1997 748-762
9. T.J. Iveson T. Hickish C. Schmitt E. Van Cutsem Irinotecan in second-line treatment of metastatic colorectal cancer: Improved survival and cost-effect compared with infusional 5-FU Eur J Cancer 35 1999 1796-1804
10. D.G. Jayne S. Fook C. Loi F. Seow-Choen Peritoneal carcinomatosis from colorectal cancer Br J Surg 89 2002 1545-1550
11. B. Sadeghi et al. Peritoneal carcinomatosis from non-gynecologic malignancies: Results of the EVOCAPE 1 multicentric prospective study Cancer 88 2000 358-363
12. E.A. Marcus et al. Prognostic factors affecting survival in patients with colorectal carcinomatosis Cancer Invest 17 1999 249-252
13. R.P. Sticca Peritoneal carcinomatosis: A final frontier Ann Surg Oncol 10 2003 484-485
14. P.H. Sugarbaker Carcinomatosis-is cure an option? J Clin Oncol 21 2003 762-764
15. V.J. Verwaal et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer J Clin Oncol 21 2003 3737-3743
16. L.R. Laufman K.A. Krzeczowski R. Roach M. Segal Leucovorin plus 5-fluorouracil: An effective treatment for metastatic colon cancer J Clin Oncol 5 1987 1394-1400
17. Y. Shimada P. Rougier H. Pitot Efficacy of CPT-11 (irinotecan) as a single agent in metastatic colorectal cancer Eur J Cancer 32A Suppl 3 1996 S13-S17
18. D.M. Elias J.F. Ouellet Intraperitoneal chemohyperthermia: Rationale, technique, indications, and results Surg Oncol Clin N Am 10 2001 915-933
19. P.H. Sugarbaker Patient selection and treatment of peritoneal carcinomatosis from colorectal and appendiceal cancer World J Surg 19 1995 235-240
20. R. Cortina J. McCormick P. Kolm R.R. Perry Management and prognosis of adenocarcinoma of the appendix Dis Colon Rectum 38 1995 848-852
21. G.M. Proulx C.G. Willett W. Daley P.C. Shellito Appendiceal carcinoma: Patterns of failure following surgery and implications for adjuvant therapy J Surg Oncol 66 1997 51-53
22. B.E. Miller B. Pittman J.Y. Wan M. Fleming Colon cancer with metastasis to the ovary at time of initial diagnosis Gynecol Oncol 66 1997 368-371
23. J. Taieb et al. Intensive systemic chemotherapy combined with surgery for metastatic colorectal cancer: Results of a phase II study J Clin Oncol 23 2005 502-509
24. C. Tournigand et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: A randomized GERCOR study J Clin Oncol 22 2004 229-237
25. D. Cunningham et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer N Engl J Med 351 2004 337-345
26. H. Hurwitz Integrating the anti-VEGF-A humanized monoclonal antibody bevacizumab with chemotherapy in advanced colorectal cancer Clin Colorectal Cancer 4 Suppl 2 2004 S62-S68